{"disease":{"id":"fuchs-endothelial-corneal-dystrophy","name":"fuchs endothelial corneal dystrophy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07117071","title":"Prevalence of Fuchs Endothelial Corneal Dystrophy in a Population of Dermatology Patients.","phase":"","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT06859411","title":"Prognosis of Posterior Lamellar Keratoplasty, an Observational Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Centre Hospitalier Régional Metz-Thionville","has_results":false},{"nct_id":"NCT07217249","title":"Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":570,"lead_sponsor_name":"Case Western Reserve University","has_results":false},{"nct_id":"NCT06881771","title":"FECD-TRACE: Fuchs' Endothelial Corneal Dystrophy TRAjectory and Correlation With Genotype in the United Kingdom","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT03974230","title":"Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France.","phase":"","overall_status":"COMPLETED","enrollment_count":208,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT05531760","title":"Predictive Factors of Graft Detachment Following Dmek","phase":"","overall_status":"COMPLETED","enrollment_count":170,"lead_sponsor_name":"Centre Hospitalier Régional Metz-Thionville","has_results":false},{"nct_id":"NCT05826353","title":"A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Kowa Research Institute, Inc.","has_results":false},{"nct_id":"NCT05795699","title":"A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Kowa Research Institute, Inc.","has_results":false},{"nct_id":"NCT05376176","title":"A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Santen Inc.","has_results":false},{"nct_id":"NCT03763721","title":"The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation","phase":"NA","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT04250207","title":"Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Kowa Research Institute, Inc.","has_results":true},{"nct_id":"NCT06969586","title":"The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":50,"lead_sponsor_name":"University Hospital Dubrava","has_results":false},{"nct_id":"NCT04440280","title":"Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false},{"nct_id":"NCT04894110","title":"Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Emmecell","has_results":false},{"nct_id":"NCT04191629","title":"Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":35,"lead_sponsor_name":"Valeria Sanchez-Huerta","has_results":false},{"nct_id":"NCT04520321","title":"A Phase 1/ Phase 2 Study of TTHX1114(NM141)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Trefoil Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03575130","title":"Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":21,"lead_sponsor_name":"University of Erlangen-Nürnberg Medical School","has_results":false},{"nct_id":"NCT05052554","title":"Study With QR-504a to Evaluate Safety, Tolerability & Corneal Endothelium Molecular Biomarker(s) in Subjects With FECD3","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"ProQR Therapeutics","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}